Posted on August 26, 2020 by Sitemaster
Some readers are probably going to find this very hard to believe, but … according to a newly published study, men initially diagnosed with metastatic prostate cancer are actually less likely to die from their cancer than men who are initially diagnosed with non-metastatic disease but who progress to having metastatic disease over time. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: cancer-specific, Diagnosis, metastatic, mortality, survival | 5 Comments »
Posted on April 11, 2019 by Sitemaster
A newly published article in this month’s Journal of Urology has suggested that being exposed to Agent Orange and getting prostate cancer comes with better overall survival data than if one gets prostate cancer some other way. … READ MORE …
Filed under: Uncategorized | Tagged: ADT, agent, androgen, cancer-specific, deprivation, exposure, Orange, prostate, survival | 2 Comments »
Posted on January 17, 2018 by Sitemaster
Two questions that come up regularly are whether: (a) men who are said to have died of prostate cancer actually did, and (b) men with prostate cancer who are said to have died of something else actually died of their prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: accuracy, cancer-specific, cause, death, mortality | 4 Comments »
Posted on November 16, 2017 by Sitemaster
A newly published study entitled “Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study” is important … but needs to be interpreted with a significant degree of caution. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: cancer-specific, metastatic, mortality, overall, survival, Treatment | 3 Comments »
Posted on October 13, 2017 by Sitemaster
A newly published study in the journal Urology (“the Gold journal”) has reported data on risk of death from prostate cancer and other causes among > 3,000 contemporary patients diagnosed with non-metastatic prostate cancer in 2004-2005. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer-specific, mortality, Norway, overall, rate, risk | 4 Comments »
Posted on March 15, 2016 by Sitemaster
According to a media release and a presentation given at the European Association of Urology (EAU) in Europe this week, statin therapy has a small but significant impact on overall and prostate cancer-specific mortality rates. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: all-cause, cancer-specific, mortality, prostate, statin, survival | 6 Comments »
Posted on August 28, 2012 by Sitemaster
A study based on the CaPSURE database, and just published in the Journal of Oncology, has again suggested that prostate cancer patients who are regular users of anticoagulant are a lower risk of prostate cancer-specific mortality than non-aspirin users. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anticoagulant, aspirin, cancer-specific, mortality | Leave a comment »
Posted on November 24, 2011 by Sitemaster
A new report in Lancet Oncology offers guidance on which patients with prostate cancer who are initially treated with radiotherapy and 6 months of neoadjuvant androgen deprivation therapy (ADT) are at relatively high and relatively low levels of risk for prostate cancer-specific mortality. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen deprivation, cancer-specific, marker, mortality, neoadjuvant, progression, PSA, radiation, surrogate | 2 Comments »
Posted on October 13, 2010 by Sitemaster
According to a media release from Myriad Genetics, the company’s investigational genetic test (Prolaris™) can accurately predict prostate cancer-specific mortality at 10 years in men known to have clinically localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cancer-specific, genes, mortality, prognosis, PROLARIS, test | 4 Comments »
Posted on July 12, 2010 by Sitemaster
It is well understood that a diagnosis of prostate cancer does not necessarily imply that the patient will ever have progressive disease — let alone that he will die of prostate cancer. Indeed, the number of men in America who die of prostate cancer today is believed to be significantly less than three for every 100 men diagnosed. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: baseline, cancer-specific, mortality, PSA, risk | 6 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 